The following is a summary of “Exploration of the association between 91 inflammatory proteins and immune thrombocytopenia: a ...

EDEN — Emergency Department Nurse, Maggie Reeder, RN, was honored with The DAISY Award for Extraordinary Nurses at UNC Health Rockingham. Nursing leadership along with senior administrators gathered o ...

The following is a summary of “Mendelian randomization reveals causal effect of Hashimoto's thyroiditis on immune ...

Students from the Lakeland and beyond showcased projects tackling complex scientific challenges at the 2025 Lakeland Regional ...

Measles is making a troubling comeback in the U.S., driven by declining vaccination rates and rising vaccine hesitancy.

ITP (immune thrombocytopenia) is an autoimmune disorder where the body attacks its own blood platelets. This leads to a ...

Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder where the body does not produce enough platelets. It is usually triggered by a recent viral infection, where young children develop ...

PTP is characterized by the development of severe, sudden and self-limiting thrombocytopenia occurring 5-10 days after a blood transfusion. The recipients always have a history of sensitization ...

A low platelet count—also called thrombocytopenia—means your blood has fewer than 150,000 platelets per microliter. Platelets are cells that help your blood clot. Without enough platelets, your body ...

A new case report from Japan details the experience of a patient with concomitant multiple sclerosis (MS) and idiopathic thrombocytopenic purpura, now commonly known as immune thrombocytopenia (ITP).

Sanofi's reversible BTK inhibitor rilzabrutinib has gained the US Food and Drug Administration’s (FDA) orphan drug designation.

The therapy is also being reviewed in the European Union (EU), China and the US for immune thrombocytopenia (ITP). The FDA has set a target action date of 29 August 2025 for its decision on ITP ...